Both in Pharmaceuticals
Korro Bio vs Standard BioTools
Over the past year KRRO returned −50.9% and LAB returned −48.2%; their daily moves had a correlation of 0.03.
KRRO −50.9% LAB −48.2%Growth of $1, one year, split-adjusted
| Metric | KRRO | LAB |
|---|---|---|
| Price | $16.62 | $0.6160 |
| Market cap | $244.7M | $243.1M |
| Today | +4.79% | +0.85% |
| 1 month | +70.3% | −14.7% |
| 6 months | +24.6% | −36.4% |
| Year to date | +107.5% | −51.9% |
| 1 year | −54.9% | −50.3% |
| Revenue growth (YoY) | −100.0% | −0.9% |
| Gross margin | — | 55.9% |
| Net margin | — | 69.6% |
| P/E (TTM) | — | 1.8× |
| Price / sales | 102.7× | 2.9× |
| Net cash | $115.0M | $460.8M |
| Dividend yield | — | — |
| Volatility (60d) | 96.1% | 45.6% |
| Short % of float | 14.8% | 1.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).